Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis

Fig. 1

Chronic phase glibenclamide improves neurological symptoms in EAE. Mean ± SE of clinical scores following EAE induction, for untreated EAE mice, for EAE mice treated with glibenclamide starting on pid-12 (red arrow, red symbols), and for EAE mice treated with glibenclamide starting on pid-24 (green arrow; green symbols); 10–12 mice/group; see Table 2 for statistical analysis

Back to article page